Literature DB >> 23238983

Tumor suppressor gene p16/INK4A/CDKN2A-dependent regulation into and out of the cell cycle in a spontaneous canine model of breast cancer.

Payal Agarwal1, Maninder Sandey, Patricia DeInnocentes, R Curtis Bird.   

Abstract

p16/INK4A/CDKN2A is an important tumor suppressor gene that arrests cell cycle in G1 phase inhibiting binding of CDK4/6 with cyclin D1, leaving the Rb tumor suppressor protein unphosphorylated and E2F bound and inactive. We hypothesized that p16 has a role in exit from cell cycle that becomes defective in cancer cells. Well characterized p16-defective canine mammary cancer cell lines (CMT28, CMT27, and CMT12), derived stably p16-transfected CMT cell clones (CMT27A, CMT27H, CMT28A, and CMT28F), and normal canine fibroblasts (NCF), were used to investigate expression of p16 after serum starvation into quiescence followed by re-feeding to induce cell cycle re-entry. The parental CMT cell lines used lack p16 expression either at the mRNA or protein expression levels, while p27 and other p16-associated proteins, including CDK4, CDK6, cyclin D1, and Rb, were expressed. We have successfully demonstrated cell cycle arrest and relatively synchronous cell cycle re-entry in parental CMT12, CMT28 and NCF cells as well as p16 transfected CMT27A, CMT27H, CMT28A, and CMT28F cells and confirmed this by (3)H-thymidine incorporation and flow cytometric analysis of cell cycle phase distribution. p16-transfected CMT27A and CMT27H cells exited cell cycle post-serum-starvation in contrast to parental CMT27 cells. NCF, CMT27A, and CMT28F cells expressed upregulated levels of p27 and p16 mRNA, post-serum starvation, as cells exited cell cycle and entered quiescence. Because quiescence and differentiation are associated with increased levels of p27, our data demonstrating that p16 was upregulated along with p27 during quiescence, suggests a potential role for p16 in maintaining these non-proliferative states.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23238983     DOI: 10.1002/jcb.24476

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro.

Authors:  Melanie Arul; April Camilla Roslani; Swee Hung Cheah
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-01-24       Impact factor: 2.416

2.  The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage.

Authors:  Seda Turgut; Muzaffer Ilhan; Saime Turan; Ozcan Karaman; Ilhan Yaylim; Ozlem Kucukhuseyin; Ertugrul Tasan
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

3.  In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers.

Authors:  Sita S Withers; Daniel York; Eric Johnson; Sami Al-Nadaf; Katherine A Skorupski; Carlos O Rodriguez; Jenna H Burton; Teri Guerrero; Kriste Sein; Luke Wittenburg; Robert B Rebhun
Journal:  Vet Comp Oncol       Date:  2018-08-08       Impact factor: 2.613

4.  Evaluation of 14-3-3 sigma as a potential partner of p16 in quiescence and differentiation.

Authors:  Payal Agarwal; Patricia DeInnocentes; R Curtis Bird
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-30       Impact factor: 2.416

5.  Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.

Authors:  Farruk M Lutful Kabir; Patricia DeInnocentes; Allison Church Bird; R Curtis Bird
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-05-20       Impact factor: 2.416

6.  MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome.

Authors:  Kunning Wang; Qiaoyi Liang; Xiaoxing Li; Ho Tsoi; Jingwan Zhang; Hua Wang; Minnie Y Y Go; Philip W Y Chiu; Enders K W Ng; Joseph J Y Sung; Jun Yu
Journal:  Gut       Date:  2015-07-23       Impact factor: 23.059

Review 7.  P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA.

Authors:  Yin Tang; Changchun Yang; Zonghui Guo; Youwei Fu; Xiao Yu; Binggen Liu; Haier Zhou; Junjie Wang; Weilong Li; Qingjiang Pang
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

8.  Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.

Authors:  Shahid Hussain; Sonal Saxena; Sameer Shrivastava; Ashok Kumar Mohanty; Sudarshan Kumar; Rajkumar James Singh; Abhinav Kumar; Sajad Ahmad Wani; Ravi Kumar Gandham; Naveen Kumar; Anil Kumar Sharma; Ashok Kumar Tiwari; Raj Kumar Singh
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

Review 9.  Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes.

Authors:  Ayumi Fujimoto; Ritsuro Suzuki
Journal:  Cancers (Basel)       Date:  2020-02-01       Impact factor: 6.639

10.  Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer.

Authors:  Farruk M Lutful Kabir; Patricia DeInnocentes; Payal Agarwal; Christopher P Mill; David J Riese Nd; R Curtis Bird
Journal:  J Vet Sci       Date:  2017-06-30       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.